Allergy and Immunology
Showing page 10 of 24 pages of list content
-
In-hospital mortality due to breakthrough COVID-19 among recipients of COVISHIELD (ChAdOx nCoV-19) and COVAXIN (BBV152)
This article's authors -
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
This article's authors -
Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated vaccine
This article's authors -
Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination
This article's authors -
In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens
This article's authors -
Immunogenicity of heterologous prime/boost inactivated and mRNA COVID-19 vaccine
This article's authors -
Immunogenicity and safety of the homogenous booster shot of a recombinant fusion protein vaccine (V-01) against COVID-19 in healthy adult participants primed with a two-dose regimen
This article's authors -
Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccines in healthy adults
This article's authors -
Whole-Blood DNA Methylation Analysis Reveals Respiratory Environmental Traits Involved in COVID-19 Severity Following SARS-CoV-2 Infection
This article's authors -
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
This article's authors